aTyr Pharma Stock (NASDAQ: ATYR) stock price, news, charts, stock research, profile.
Open | $1.53 |
Close | $1.56 |
Volume / Avg. | 193.25K / 459.47K |
Day Range | 1.49 - 1.57 |
52 Wk Range | 1.42 - 2.07 |
Market Cap | $107.66M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 0.57% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of aTyr Pharma (NASDAQ:ATYR) through any online brokerage.
Other companies in aTyr Pharma’s space includes: CytomX Therapeutics (NASDAQ:CTMX), T2 Biosystems (NASDAQ:TTOO), FibroGen (NASDAQ:FGEN), Armata Pharmaceuticals (AMEX:ARMP) and Vistagen Therapeutics (NASDAQ:VTGN).
There is no analysis for aTyr Pharma.
There is no analysis for aTyr Pharma to provide a consensus price target.
The stock price for aTyr Pharma (NASDAQ: ATYR) is $1.56 last updated June 28, 2024 at 7:45 PM EDT.
There are no upcoming dividends for aTyr Pharma.
aTyr Pharma’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for aTyr Pharma.
aTyr Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.